174 related articles for article (PubMed ID: 38180275)
1. Characterization of integrated hepatitis B virus DNA harboring pre-S mutations in hepatocellular carcinoma patients with ground glass hepatocytes.
Su YP; Lin SY; Su IJ; Kao YL; Shen SC; Earl JP; Ehrlich GD; Chen CY; Huang W; Su YH; Tsai HW
J Med Virol; 2024 Jan; 96(1):e29348. PubMed ID: 38180275
[TBL] [Abstract][Full Text] [Related]
2. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
4. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection.
Su IJ; Wang HC; Wu HC; Huang WY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1169-74. PubMed ID: 18505413
[TBL] [Abstract][Full Text] [Related]
5. Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
Ramirez R; van Buuren N; Gamelin L; Soulette C; May L; Han D; Yu M; Choy R; Cheng G; Bhardwaj N; Chiu J; Muench RC; Delaney WE; Mo H; Feierbach B; Li L
J Virol; 2021 Sep; 95(19):e0029921. PubMed ID: 34287049
[TBL] [Abstract][Full Text] [Related]
6. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC
PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
Mathkar PP; Chen X; Sulovari A; Li D
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
[TBL] [Abstract][Full Text] [Related]
9. Approaches for Detection of Hepatitis B Virus Pre-S Gene Deletions and Pre-S Deleted Proteins and Their Application in Prediction of Higher Risk of Hepatocellular Carcinoma Development and Recurrence.
Lin YT; Jeng LB; Su IJ; Teng CF
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216021
[TBL] [Abstract][Full Text] [Related]
10. Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment.
Grudda T; Hwang HS; Taddese M; Quinn J; Sulkowski MS; Sterling RK; Balagopal A; Thio CL
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35797115
[TBL] [Abstract][Full Text] [Related]
11. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
[TBL] [Abstract][Full Text] [Related]
12. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
Chen CH; Changchien CS; Lee CM; Tung WC; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
Int J Cancer; 2009 Aug; 125(3):621-9. PubMed ID: 19431214
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.
Su IJ; Wang LH; Hsieh WC; Wu HC; Teng CF; Tsai HW; Huang W
J Biomed Sci; 2014 Oct; 21(1):98. PubMed ID: 25316153
[TBL] [Abstract][Full Text] [Related]
14. Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.
Teng CF; Wu HC; Tsai HW; Shiah HS; Huang W; Su IJ
Hepatology; 2011 Oct; 54(4):1199-207. PubMed ID: 21735472
[TBL] [Abstract][Full Text] [Related]
15. Detection of Hepatitis B Virus-Host Junction Sequences in Urine of Infected Patients.
Lin SY; Su YP; Trauger ER; Song BP; Thompson EGC; Hoffman MC; Chang TT; Lin YJ; Kao YL; Cui Y; Hann HW; Park G; Shieh FS; Song W; Su YH
Hepatol Commun; 2021 Oct; 5(10):1649-1659. PubMed ID: 34558837
[TBL] [Abstract][Full Text] [Related]
16. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B.
Yeung P; Wong DK; Lai CL; Fung J; Seto WK; Yuen MF
J Infect Dis; 2011 Mar; 203(5):646-54. PubMed ID: 21227916
[TBL] [Abstract][Full Text] [Related]
17. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
